Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQ:COR...
3 Reasons to Sell PINC and 1 Stock to Buy Instead
Over the past six months, Premier’s shares (currently trading at $17.93) have posted a disappointing 13.5% loss, well below the S&P 500’s 6.2% gain. This was partly driven by its sof...
Winners And Losers Of Q4: Sabre (NASDAQ:SABR) Vs The Rest Of The Travel and Vacation Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Sabre (NASDA...
